GemPharmatech Co Ltd
688046
Company Profile
Business description
GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.
Contact
No. 12, Xuefu Road
Jiangbei New District, Jiangsu Province
Nanjing210032
CHNT: +86 2558243997
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,590
Stocks News & Analysis
stocks
Weekly earnings wrap: FMG, WDS, COL and more
A closer look at the final major results from August reporting season.
stocks
Chart of the Week: Are US mega-cap stocks undervalued?
Opportunities emerge across US equities.
stocks
Three overpriced ASX shares without moats to avoid
These shares are trading a significant premium to our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,338.80 | 54.50 | -0.58% |
| CAC 40 | 8,462.39 | 23.19 | 0.27% |
| DAX 40 | 26,285.96 | 19.82 | 0.08% |
| Dow JONES (US) | 53,463.88 | 113.52 | -0.21% |
| FTSE 100 | 10,878.12 | 8.04 | -0.07% |
| HKSE | 25,652.97 | 141.87 | 0.56% |
| NASDAQ | 26,130.20 | 21.10 | -0.08% |
| Nikkei 225 | 66,262.16 | 405.73 | 0.62% |
| NZX 50 Index | 14,013.21 | 20.49 | 0.15% |
| S&P 500 | 7,675.70 | 1.58 | -0.02% |
| S&P/ASX 200 | 9,127.80 | 55.90 | -0.61% |
| SSE Composite Index | 3,912.52 | 23.08 | 0.59% |